Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy

PURPOSE: Clinical studies have shown that peroxisome proliferator-activated receptor alpha (PPARα) agonist fenofibrate has therapeutic effects on diabetic retinopathy (DR). The purpose of this study was to identify a novel PPARα agonist and to evaluate its beneficial effects on DR. METHODS: The tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Guotao, Moran, Elizabeth P., Cheng, Rui, Matlock, Greg, Zhou, Kelu, Moran, David, Chen, Danyang, Yu, Qiang, Ma, Jian-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2017
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633008/
https://www.ncbi.nlm.nih.gov/pubmed/28979999
http://dx.doi.org/10.1167/iovs.16-21402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633008/
https://www.ncbi.nlm.nih.gov/pubmed/28979999
http://dx.doi.org/10.1167/iovs.16-21402

Ejemplares similares